413 related articles for article (PubMed ID: 22884313)
21. Platelet C-Type Lectin-Like Receptor 2 Reduces Cholestatic Liver Injury in Mice.
Maruyama S; Kono H; Furuya S; Shimizu H; Saito R; Shoda K; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Sudo M; Inoue S; Shirai T; Suzuki-Inoue K; Ichikawa D
Am J Pathol; 2020 Sep; 190(9):1833-1842. PubMed ID: 32473917
[TBL] [Abstract][Full Text] [Related]
22. CLEC-2-dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP.
Borgognone A; Navarro-Núñez L; Correia JN; Pollitt AY; Thomas SG; Eble JA; Pulcinelli FM; Madhani M; Watson SP
J Thromb Haemost; 2014 Apr; 12(4):550-9. PubMed ID: 24460629
[TBL] [Abstract][Full Text] [Related]
23. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
[TBL] [Abstract][Full Text] [Related]
24. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
[No Abstract] [Full Text] [Related]
25. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
[TBL] [Abstract][Full Text] [Related]
26. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology.
Suzuki-Inoue K; Tsukiji N
Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177
[TBL] [Abstract][Full Text] [Related]
27. CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice.
Otake S; Sasaki T; Shirai T; Tsukiji N; Tamura S; Takano K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2021 Jun; 19(6):1572-1584. PubMed ID: 33774924
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
[TBL] [Abstract][Full Text] [Related]
29. Leishmania donovani Attenuates Dendritic Cell Trafficking to Lymph Nodes by Inhibiting C-Type Lectin Receptor 2 Expression via Transforming Growth Factor-β.
Yadav M; Akhtar MN; Mishra M; Kumar S; Kumar R; Shubham ; Nandal A; Sen P
Microbiol Spectr; 2023 Jun; 11(3):e0412222. PubMed ID: 37125906
[TBL] [Abstract][Full Text] [Related]
30. Novel platelet activation receptor CLEC-2: from discovery to prospects.
Suzuki-Inoue K; Inoue O; Ozaki Y
J Thromb Haemost; 2011 Jul; 9 Suppl 1():44-55. PubMed ID: 21781241
[TBL] [Abstract][Full Text] [Related]
31. [CLEC-2 induced signalling in blood platelets].
Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
[TBL] [Abstract][Full Text] [Related]
32. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
Hur J; Jang JH; Oh IY; Choi JI; Yun JY; Kim J; Choi YE; Ko SB; Kang JA; Kang J; Lee SE; Lee H; Park YB; Kim HS
Mol Ther; 2014 Aug; 22(8):1518-1529. PubMed ID: 24736277
[TBL] [Abstract][Full Text] [Related]
33. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
[TBL] [Abstract][Full Text] [Related]
34. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
[TBL] [Abstract][Full Text] [Related]
35. The physiological and pathophysiological roles of platelet CLEC-2.
Navarro-Núñez L; Langan SA; Nash GB; Watson SP
Thromb Haemost; 2013 Jun; 109(6):991-8. PubMed ID: 23572154
[TBL] [Abstract][Full Text] [Related]
36. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
[TBL] [Abstract][Full Text] [Related]
37. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y
PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
39. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-β1 impairs lymph node homing of dendritic cells by downregulating C-type lectin receptor-2 expression.
Gujar R; Sen P
Cytokine; 2018 Oct; 110():39-43. PubMed ID: 29702464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
